Asia Pacific Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Human Insulin Market would witness market growth of 3.8% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,577.9 million by 2031. The Japan market is registering a CAGR of 3.2% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 4.5% during (2024 - 2031).

Technological advancements in biotechnology have significantly transformed the insulin market, developing more effective and safer insulin analogs. These innovations have improved patient outcomes and driven market expansion by addressing some of the key limitations of traditional insulin therapies. Insulin analogs are modified insulin forms that mimic the body’s natural insulin release patterns. Unlike regular insulin, which has a standard action profile, insulin analogs can be engineered to have different onset times, peak activity periods, and durations of action. This enables the management of blood glucose levels to be more precise and adaptable. 

Advances in genetic engineering and protein modification technologies have driven the development of these analogs. Scientists have developed molecules with enhanced pharmacokinetic properties by modifying the amino acid sequence of insulin, thereby improving their absorption, distribution, metabolism, and excretion profiles. These modifications have led to insulin analogs that are more effective in controlling blood glucose levels and offer a lower risk of adverse effects, such as hypoglycemia, a common and potentially dangerous side effect of insulin therapy.

The Asia Pacific region is experiencing a dramatic surge in diabetes cases, primarily Type 2 diabetes, fueled by urbanization, sedentary lifestyles, and dietary changes. This escalating patient population is driving a robust demand for insulin therapies, including human insulin. In Asia Pacific, diabetes affects more than 60% of the population, with China and India having the highest rates. According to the World Health Organization, in the Western Pacific, there are already more than 131 million diabetics, with 201 million expected by 2035. According to the National Library of Medicine, between 2000 and 2035, the proportion of diabetics is supposed to increase by 150% in South Asia. Several prominent government programs and initiatives address Australia's increasing demand for this insulin. The National Diabetes Services Scheme (NDSS), funded by the Australian government, provides subsidized access to diabetes-related products, including insulin, and supports diabetes education and management. The Australian National Diabetes Strategy 2016–2020 outlines a national framework for improving diabetes prevention, care, and research. This strategy emphasizes early detection, effective management, and reducing the impact of diabetes-related complications. Australia's Medicare system also provides coverage for diabetes management services, ensuring that insulin and other essential treatments are affordable and accessible to all Australians. Thus, the increasing prevalence of diabetes and rising government support for raising awareness of the disease are the leading factors driving the expansion of the regional market.

Free Valuable Insights: The Global Human Insulin Market is Predict to reach USD 20.5 Billion by 2031, at a CAGR of 3.2%

Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• MannKind Corporation
• Lupin Limited
• Sanofi S.A.
• Novo Nordisk A/S
• Eli Lilly And Company
• Medtronic PLC
• Biocon Limited
• Tonghua Dongbao Pharmaceutical Co., Ltd.
• Pfizer, Inc.

Asia Pacific Human Insulin Market Report Segmentation

By Indication

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

By Product Type

• Pens
• Syringes
• Others

By Type of Insulin

• Rapid-acting insulin
• Short-acting insulin
• Intermediate-acting insulin
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Providers

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Human Insulin Market, by Indication
1.4.2 Asia Pacific Human Insulin Market, by Product Type
1.4.3 Asia Pacific Human Insulin Market, by Type of Insulin
1.4.4 Asia Pacific Human Insulin Market, by Distribution Channel
1.4.5 Asia Pacific Human Insulin Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Human Insulin Market by Indication
4.1 Asia Pacific Type 1 Diabetes Market by Country
4.2 Asia Pacific Type 2 Diabetes Market by Country
4.3 Asia Pacific Gestational Diabetes Market by Country

Chapter 5. Asia Pacific Human Insulin Market by Product Type
5.1 Asia Pacific Pens Market by Country
5.2 Asia Pacific Syringes Market by Country
5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Human Insulin Market by Type of Insulin
6.1 Asia Pacific Rapid-acting insulin Market by Country
6.2 Asia Pacific Short-acting insulin Market by Country
6.3 Asia Pacific Intermediate-acting insulin Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Human Insulin Market by Distribution Channel
7.1 Asia Pacific Hospital Pharmacies Market by Country
7.2 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
7.3 Asia Pacific Online Providers Market by Country

Chapter 8. Asia Pacific Human Insulin Market by Country
8.1 China Human Insulin Market
8.1.1 China Human Insulin Market by Indication
8.1.2 China Human Insulin Market by Product Type
8.1.3 China Human Insulin Market by Type of Insulin
8.1.4 China Human Insulin Market by Distribution Channel
8.2 Japan Human Insulin Market
8.2.1 Japan Human Insulin Market by Indication
8.2.2 Japan Human Insulin Market by Product Type
8.2.3 Japan Human Insulin Market by Type of Insulin
8.2.4 Japan Human Insulin Market by Distribution Channel
8.3 India Human Insulin Market
8.3.1 India Human Insulin Market by Indication
8.3.2 India Human Insulin Market by Product Type
8.3.3 India Human Insulin Market by Type of Insulin
8.3.4 India Human Insulin Market by Distribution Channel
8.4 South Korea Human Insulin Market
8.4.1 South Korea Human Insulin Market by Indication
8.4.2 South Korea Human Insulin Market by Product Type
8.4.3 South Korea Human Insulin Market by Type of Insulin
8.4.4 South Korea Human Insulin Market by Distribution Channel
8.5 Singapore Human Insulin Market
8.5.1 Singapore Human Insulin Market by Indication
8.5.2 Singapore Human Insulin Market by Product Type
8.5.3 Singapore Human Insulin Market by Type of Insulin
8.5.4 Singapore Human Insulin Market by Distribution Channel
8.6 Malaysia Human Insulin Market
8.6.1 Malaysia Human Insulin Market by Indication
8.6.2 Malaysia Human Insulin Market by Product Type
8.6.3 Malaysia Human Insulin Market by Type of Insulin
8.6.4 Malaysia Human Insulin Market by Distribution Channel
8.7 Rest of Asia Pacific Human Insulin Market
8.7.1 Rest of Asia Pacific Human Insulin Market by Indication
8.7.2 Rest of Asia Pacific Human Insulin Market by Product Type
8.7.3 Rest of Asia Pacific Human Insulin Market by Type of Insulin
8.7.4 Rest of Asia Pacific Human Insulin Market by Distribution Channel

Chapter 9. Company Profiles
9.1 Biocon Limited
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Research & Development Expenses
9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
9.2.1 Company Overview
9.3 Lupin Limited
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 SWOT Analysis
9.4 MannKind Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Sanofi S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Novo Nordisk A/S
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental & Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 SWOT Analysis
9.7 Medtronic PLC
9.7.1 Company overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Eli Lilly And Company
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis

TABLE 1 Asia Pacific Human Insulin Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Human Insulin Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Gestational Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Gestational Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Pens Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Pens Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Syringes Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Syringes Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Short-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Short-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 31 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 32 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 33 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 34 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 35 Asia Pacific Online Providers Market by Country, 2020 - 2023, USD Million
TABLE 36 Asia Pacific Online Providers Market by Country, 2024 - 2031, USD Million
TABLE 37 Asia Pacific Human Insulin Market by Country, 2020 - 2023, USD Million
TABLE 38 Asia Pacific Human Insulin Market by Country, 2024 - 2031, USD Million
TABLE 39 China Human Insulin Market, 2020 - 2023, USD Million
TABLE 40 China Human Insulin Market, 2024 - 2031, USD Million
TABLE 41 China Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 42 China Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 43 China Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 44 China Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 45 China Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 46 China Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 47 China Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 48 China Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 49 Japan Human Insulin Market, 2020 - 2023, USD Million
TABLE 50 Japan Human Insulin Market, 2024 - 2031, USD Million
TABLE 51 Japan Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 52 Japan Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 53 Japan Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 54 Japan Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 55 Japan Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 56 Japan Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 57 Japan Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 58 Japan Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 59 India Human Insulin Market, 2020 - 2023, USD Million
TABLE 60 India Human Insulin Market, 2024 - 2031, USD Million
TABLE 61 India Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 62 India Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 63 India Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 64 India Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 65 India Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 66 India Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 67 India Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 68 India Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 69 South Korea Human Insulin Market, 2020 - 2023, USD Million
TABLE 70 South Korea Human Insulin Market, 2024 - 2031, USD Million
TABLE 71 South Korea Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 72 South Korea Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 73 South Korea Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 74 South Korea Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 75 South Korea Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 76 South Korea Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 77 South Korea Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 South Korea Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Singapore Human Insulin Market, 2020 - 2023, USD Million
TABLE 80 Singapore Human Insulin Market, 2024 - 2031, USD Million
TABLE 81 Singapore Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 82 Singapore Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 83 Singapore Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 84 Singapore Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 85 Singapore Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 86 Singapore Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 87 Singapore Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 88 Singapore Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 89 Malaysia Human Insulin Market, 2020 - 2023, USD Million
TABLE 90 Malaysia Human Insulin Market, 2024 - 2031, USD Million
TABLE 91 Malaysia Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 92 Malaysia Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 93 Malaysia Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 94 Malaysia Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 95 Malaysia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 96 Malaysia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 97 Malaysia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 98 Malaysia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 99 Rest of Asia Pacific Human Insulin Market, 2020 - 2023, USD Million
TABLE 100 Rest of Asia Pacific Human Insulin Market, 2024 - 2031, USD Million
TABLE 101 Rest of Asia Pacific Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 102 Rest of Asia Pacific Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 103 Rest of Asia Pacific Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 104 Rest of Asia Pacific Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 105 Rest of Asia Pacific Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 106 Rest of Asia Pacific Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 107 Rest of Asia Pacific Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 108 Rest of Asia Pacific Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 109 Key Information – Biocon Limited
TABLE 110 Key Information – Tonghua Dongbao Pharmaceutical Co., Ltd.
TABLE 111 Key Information – Lupin Limited
TABLE 112 Key Information – MannKind Corporation
TABLE 113 Key Information – Sanofi S.A.
TABLE 114 Key Information – Novo Nordisk A/S
TABLE 115 Key Information – Medtronic PLC
TABLE 116 Key Information – Eli Lilly And Company
TABLE 117 Key Information – Pfizer, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Human Insulin Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Human Insulin Market
FIG 4 Porter’s Five Forces Analysis – Human Insulin Market
FIG 5 Asia Pacific Human Insulin Market share by Indication, 2023
FIG 6 Asia Pacific Human Insulin Market share by Indication, 2031
FIG 7 Asia Pacific Human Insulin Market by Indication, 2020 - 2031, USD Million
FIG 8 Asia Pacific Human Insulin Market share by Product Type, 2023
FIG 9 Asia Pacific Human Insulin Market share by Product Type, 2031
FIG 10 Asia Pacific Human Insulin Market by Product Type, 2020 - 2031, USD Million
FIG 11 Asia Pacific Human Insulin Market share by Type of Insulin, 2023
FIG 12 Asia Pacific Human Insulin Market share by Type of Insulin, 2031
FIG 13 Asia Pacific Human Insulin Market by Type of Insulin, 2020 - 2031, USD Million
FIG 14 Asia Pacific Human Insulin Market share by Distribution Channel, 2023
FIG 15 Asia Pacific Human Insulin Market share by Distribution Channel, 2031
FIG 16 Asia Pacific Human Insulin Market by Distribution Channel, 2020 - 2031, USD Million
FIG 17 Asia Pacific Human Insulin Market share by Country, 2023
FIG 18 Asia Pacific Human Insulin Market share by Country, 2031
FIG 19 Asia Pacific Human Insulin Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Lupin Limited
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Novo Nordisk A/S
FIG 23 SWOT Analysis: Medtronic PLC
FIG 24 Swot Analysis: Eli Lilly And Company
FIG 25 SWOT Analysis: Pfizer, Inc.